Senescent B cells gather in inflamed niches of COPD lungs
A paper examined lung tissue from COPD patients and healthy controls, six per group, including smokers and non-smokers. It profiled 121,885 cells. COPD B-cell clusters showed enriched senescence signatures. The profile includes impaired maturation, IL6 and MMP14. Spatial measurements found p16-linked niches and ADGRE5-CD55 contacts between B cells and alveolar type II cells. The mapping is observational. Separate drug experiments on cultured airway cells changed some markers without fully reversing senescence; patient treatment outcomes were not measured.
Science··Midday
121,885 cells, six people in each group
Cellular senescence is already discussed as one mechanism in the chronic inflammation and airway remodelling of COPD. Which cells carry that signature, and what they do in the tissue, had been poorly mapped. The paper uses several molecular readouts on smoke-related emphysema, centred on a single-cell census of human lung.[1]
The single-cell RNA measurements cover 121,885 lung cells from people with COPD and from healthy controls, with 6 people in each group. The groups include people with a smoking history and people without one. Senescence-associated gene signatures were enriched in B-cell clusters from the COPD lungs. The enrichment is reported at p < 0.05.[1]
Maturation genes fall while IL6 and MMP14 rise in the profile
The transcriptional profile of the senescent B cells includes weaker differentiation and maturation, with KITLG and PRDM1 among the named genes. Inflammatory signalling is higher in the same profile, and IL6 is one of the named signals, along with CXCL3 and GDF15. Lipid-metabolism genes are also off the usual pattern, with PTGS2 named, and MMP14 is named among factors that can reshape the surrounding matrix.[1]
B cells and alveolar cells meet at ADGRE5 and CD55
Spatial transcriptomics and proteomics are reported as agreeing with the single-cell map. The authors describe distinct senescent niches in COPD lungs, with inflammatory signalling that persists, p16-linked senescence, and altered cell-to-cell communication. Inside those regions, contacts between B cells and alveolar type II cells shift toward the pair ADGRE5 and CD55.[1]
The lung-cell mapping is observational and cannot establish that removing senescent B cells would improve breathlessness or change the course of COPD. The same paper also tested drugs in cultured airway epithelial cells. Those experiments changed some inflammatory signals and senescence markers, but did not fully reverse the senescence signature. They provide laboratory results, without measuring treatment benefit in patients.[1]
